Karyopharm Therapeutics Inc. Stock
Karyopharm Therapeutics Inc. is currently one of the favorites of our community with 14 Buy predictions and no Sell predictions.
With a target price of 14 € there is potential for a 2486.84% increase which would mean more than doubling the current price of 0.54 € for Karyopharm Therapeutics Inc..
Our community identified positive and negative aspects for Karyopharm Therapeutics Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Karyopharm Therapeutics Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Karyopharm Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karyopharm Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc. | - | - | - | - | - | - | - |
| Ardelyx Inc. | -2.350% | 4.231% | 4.603% | 5.906% | 6.183% | 185.065% | -8.694% |
| Krystal Biotech | -1.400% | 2.833% | 17.993% | 32.628% | 35.940% | 191.408% | - |
| Evolus Inc | 0.860% | 1.754% | -5.691% | -45.794% | -44.762% | -10.769% | 86.435% |
Comments
Karyopharm Therapeutics (NASDAQ:KPTI) had its price target lowered by analysts at Royal Bank Of Canada from $30.00 to $19.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for KPTI provided by MarketBeat
Karyopharm Therapeutics (NASDAQ:KPTI) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $15.00 price target on the stock.
Show more
Ratings data for KPTI provided by MarketBeat
Karyopharm Therapeutics (NASDAQ:KPTI) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $12.00 price target on the stock, down previously from $15.00.
Show more
Ratings data for KPTI provided by MarketBeat